Systemic Toxicity of Intraperitoneal Vancomycin
Intraperitoneal vancomycin is used for empiric treatment of peritoneal dialysis peritonitis. It is dosed intermittently and a high systemic concentration is often achieved. Despite this, there are very few reports of systemic toxicity from intraperitoneal vancomycin. We report the course of a patien...
Saved in:
Main Authors: | Teerath Kumar, Iris Teo, Brendan B. McCormick |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Case Reports in Nephrology |
Online Access: | http://dx.doi.org/10.1155/2016/3968690 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biopsy-Proven Acute Tubular Necrosis due to Vancomycin Toxicity
by: Farheen Shah-Khan, et al.
Published: (2011-01-01) -
Hyperthermic intraperitoneal chemotherapy (HIPEC) increases risk of local anesthetic systemic toxicity (LAST)
by: Masahiko Tsuchiya, et al.
Published: (2025-01-01) -
Toxic epidermal necrolysis induced by nivolumab therapy for unresectable intraperitoneal cancer
by: Hiroyoshi Nozaki, et al.
Published: (2025-01-01) -
Palmitoleic acid sensitizes vancomycin-resistant Staphylococcus aureus to vancomycin by outpacing the expression of resistance genes
by: Zajeba Tabashsum, et al.
Published: (2025-01-01) -
A Guide to Digital Medieval Studies in North America
by: Stephen P. McCormick
Published: (2016-01-01)